Early Access — free while we kick the tires
EdgarHawk

Nussbaum Ran

Director

Director
1 filing analyzed · 1 company · Latest 2025-09-16

Companies

Company Buys Sells Direction
LB PHARMACEUTICALS INC LBRX 2 0 Net buying

Activity

September 2025
2025-09-16 LB PHARMACEUTICALS INC LBRX
high
Buy
1,000,000 shares
$15,000,000
Significance 7/10

Director Nussbaum bought 1,000,000 shares of LBRX at $15.00 ($15.0M) in cluster with 3 other insiders in 14 days

Director Ran Nussbaum purchased 1,000,000 shares at $15.00 on 2025-09-12, increasing his position from 411,681 shares to 1,411,681 shares and representing a 242.9% increase relative to pre-transaction holdings. This purchase occurred as part of a cluster pattern, with 3 other insiders also buying within the past 14 days, suggesting coordinated board-level confidence in the stock shortly after its recent listing. The stock now trades at $15.78 as of 2025-09-16, four trading days post-purchase. The filing contains a derivative-conversion transaction; the insider's full position may include derivative securities not yet reflected in available Form 4 Table II data, so this $15.0M equity purchase represents a portion of his total investment activity, not necessarily his complete position change.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access